Qualified Temperature-Controlled Corridors: The Future is Here

A new standard is reshaping global pharmaceutical logistics. Discover how validated temperature-controlled corridors enhance compliance, reduce risk, and protect product integrity across every mile.

Register Free: https://www.pharmaceuticalcommerce.com/pc_w/validated-temp

Event Overview:

Qualified Temperature-Controlled Corridors (TCCs) are rapidly emerging as a critical solution to the growing complexity of transporting temperature-sensitive pharmaceuticals across global networks. With biologics, ATMPs, and time and temperature sensitive life science medicines expanding worldwide, the industry faces unprecedented pressure to maintain absolute temperature integrity, reduce handoffs, strengthen documentation, and ensure continuous visibility from origin to destination. This session examines how fully qualified, end-to-end corridors integrate regulatory compliance, digital telemetry, predictive analytics, and harmonised quality frameworks to minimise risk, prevent excursions, and improve operational efficiency. Attendees will gain actionable insight into evaluating corridor partners, aligning with GDP and QMS expectations, and adopting future-ready logistics models that support both supply-chain resilience and sustainability objectives.

Key Learning Objectives:

• Identify the core requirements of a qualified temperature-controlled corridor
• Evaluate corridor partners for compliance, quality, and visibility standards
• Understand how data integration reduces excursions and enhances reliability

Who Should Attend:

• Those in clinical operations, medical, and R&D; project managers, pharmaceutical decision-makers, those in biotech, and those part of medical device organizations
  
• Academic investigators and research networks
  
• Clinicians and key opinion leaders (KOLs) shaping the real-world impact of sponsor-backed trials

Speakers:

Leandro Moreira
President of Transportation
Frontier Scientific Solutions

Leandro Moreira, President of Transportation, brings over 25 years of international experience in transportation and logistics. He leads Frontier Scientific Solutions’ dedicated pharmaceutical transportation network across air, ground, and multimodal solutions, and is a recognized expert in life sciences supply chain security and innovation, regularly speaking at global industry forums

Kevin Nash CCO
Frontier Scientific Solutions

Kevin Nash, Chief Commercial Officer, brings 40 years of experience in international logistics, strategic leadership, and end-to-end supply chain management. He has held senior roles across Fortune 100 and Global Fortune 500 companies and has led global sales, marketing, and solutions delivering innovative supply chain capabilities for life sciences, pharmaceutical, and MedTech organizations at Frontier Scientific Solutions.

Perry Fri
Chief Industry Relations Officer, HDA, and President, HDA Research Foundation

Perry L. Fri is the Chief Industry Relations Officer at HDA and President of the HDA Research Foundation, where he leads member engagement through research, education, networking, and supply chain initiatives. He also serves on the board of Healthcare Ready, supporting disaster preparedness across the pharmaceutical supply chain. Previously, he held leadership roles at HIDA, The Hale Group, and Instill Corporation, and he holds a BA in History from the University of Maryland.

Kevin Larsen
Vice President, Commercial Operation
Prasco

Kevin D. Larsen is Vice President of Commercial Operations at Prasco, a Mason, Ohio–based pharmaceutical leader in Authorised Generics. Since 2017, he has shaped commercial strategy and growth, helping drive its rise as one of the fastest-growing U.S. pharma firms and the second-largest generic supplier. Previously, he held leadership roles at Omnicare.

Register Free: https://www.pharmaceuticalcommerce.com/pc_w/validated-temp